Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2200
    PDF: 1488
    HTML: 266
  • Increased mortality in male recipients of red cells from ever pregnant female donors : mHAGs on red cells to blame ?

    Kanjaksha Ghosh
    e2018009
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.009
    2836
    PDF: 658
    HTML: 389
  • TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia

    Rola Husni, Remie Chrabieh, Rita Wilson Dib, Jose Vazquez, MD, Thaís Guimarães, Ana Fernández, Rita Khoury, Lina Asmar, Georges Khazen, Nadia Lara Samaha, Issam Raad, Ray Hachem
    Page e2021031
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.031
    2066
    PDF: 648
    HTML: 264
  • DYNAMIC HEMOGLOBIN TRAJECTORIES IN RENAL ANEMIA AND THEIR ASSOCIATION WITH FRAILTY PROGRESSION AND CARDIOVASCULAR EVENTS IN NON‑DIALYSIS CHRONIC KIDNEY DISEASE

    Li Guo, Lei Ran, Zhen-Zhen Hao, Ya-Pu Zhang, Jian-Dong Li, Shan-Shan Guo
    e2026040
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.040
    160
    PDF: 189
    HTML: 18
  • MALARIA IN PREGNANCY

    Ebako Ndip Takem, Umberto D'Alessandro
    e2013010
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.010
    4861
    PDF: 2107
    HTML: 7807
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1301
    HTML: 307
    PDF: 933
    Suppl. Files: 446
  • Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio

    Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna
    e2025006
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.006
    2169
    PDF: 1586
    HTML: 265
  • REDUCTION OF INTRAMEDULLARY APOPTOSIS AFTER STEM CELL TRANSPLANTATION IN BLACK AFRICAN VARIANT OF PEDIATRIC SICKLE CELL ANEMIA.

    Antonella Isgrò, Pietro Sodani, Marco Marziali, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Daniele Armiento, Andrea Roveda, Marco Andreani, Manuela Testi, Guido Lucarelli
    e2014054
    2014-07-06
    https://doi.org/10.4084/mjhid.2014.054
    2432
    PDF: 1108
    HTML: 2112
  • LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

    kang sun
    e2024037
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.037
    2661
    PDF: 1078
    HTML: 118
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2003
    PDF: 1060
    HTML: 1197
  • MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus

    Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi
    e2012032
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.032
    2694
    PDF: 1006
    HTML: 2265
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3551
    PDF: 2411
    HTML: 1463
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1481
    PDF: 1144
    HTML: 275
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1551
    PDF: 633
    HTML: 6811
  • OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE

    Grzegorz Helbig, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien
    e2015003
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.003
    2221
    PDF: 1046
    HTML: 1982
    Characteristic of study group: 198
  • The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients

    Shuku Sato
    e2025070
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.070
    1075
    PDF: 389
    HTML: 89
  • Guest Edtor: Pellegrino Musto NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

    Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani
    e2025027
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.027
    1419
    PDF: 1221
    HTML: 267
  • THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

    Nicola Semeraro, Prof. Mario Colucci
    e2021045
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.045
    1961
    PDF: 812
    HTML: 221
  • COMPARISON OF THREE DISTINCT PROPHYLACTIC AGENTS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS UNDERGOING HAPLO-IDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION AND POST-TRANSPLANT CYCLOPHOSPHAMIDE

    Jean Elcheikh
    e2015048
    2015-08-21
    https://doi.org/10.4084/mjhid.2015.048
    1894
    PDF: 1012
    HTML: 1338
  • ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY

    Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca
    e2020075
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.075
    1515
    PDF: 1406
    HTML: 493
  • EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly

    . Maria Luigia Randi, Prof. Fabrizio Fabris
    Page e2021038
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.038
    1567
    PDF: 504
    HTML: 233
  • CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY

    Vishal Vishnu Tewari, Kunal Tewari, Ritu Mehta
    e2018021
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.021
    4178
    PDF: 1737
    HTML: 496
    Figure 1: Age distribution of Pediatric cases: 213
  • TREATMENT OF CANCER IN THE OLDER AGED PERSON

    Lodovico Balducci
    e2010029
    2010-10-01
    https://doi.org/10.4084/mjhid.2010.029
    1175
    PDF: 833
    HTML: 3361
  • CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

    Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano
    e2020042
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.042
    1426
    PDF: 936
    HTML: 324
  • IMPACT OF PRETRANSPLANT DONOR AND RECIPIENT CYTOMEGALOVIRUS SEROSTATUS ON OUTCOME FOR MULTIPLE MYELOMA PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION.

    Jean Elcheikh
    e2013026
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.026
    1286
    PDF: 737
    HTML: 1405
  • CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

    guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv
    e2022066
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.066
    973
    PDF: 633
    HTML: 234
  • POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

    Daniela Capello, Gianluca Gaidano
    e2009018
    https://doi.org/10.4084/mjhid.2009.018
    1243
    PDF: 473
    HTML: 18570
    Figure 1: 169
    Figure 2: 150
    Figure 3: 167
    Figure 4: 205
    Figure 5: 176
  • COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis

    Selim SAYIN
    e2024016
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.016
    1380
    PDF: 1306
    HTML: 99
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    6631
    PDF: 3906
    HTML: 427
  • SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

    Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2024020
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.020
    1055
    PDF: 1232
    HTML: 101
  • HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

    Francesco Lo-Coco, Laura Cicconi
    e2011067
    2011-12-21
    https://doi.org/10.4084/mjhid.2011.067
    3149
    PDF: 1114
    HTML: 1754
  • Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

    Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda
    e2025026
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.026
    1910
    PDF: 1632
    HTML: 124
  • IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

    Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria
    e2024060
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.060
    2087
    PDF: 1797
    HTML: 158
  • GUT COLONIZATION WITH CARBAPENEM RESISTANT ENTEROBACTERIACEAE ADVERSELY IMPACTS THE OUTCOME IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES: RESULTS OF A PROSPECTIVE SURVEILLANCE STUDY

    SUPARNO CHAKRABARTI
    e2018025
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.025
    3681
    PDF: 1250
    HTML: 397
  • INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    AnnaMaria Nosari
    e2012070
    2012-11-05
    https://doi.org/10.4084/mjhid.2012.070
    3298
    PDF: 1342
    HTML: 2625
  • High Tuberculosis density incidence rate in Matched Unrelated Allogeneic stem cell transplantation recipients in the state of São Paulo, Brazil

    Marcelo Nóbrega Litvoc, silvia F costa, Fabio Eudes Leal, Diogo Boldim Ferreira, Max Igor Banks Ferreira Lopes, Ligia Capuani, Vanderson Geraldo Rocha
    e2023037
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.037
    619
    PDF: 840
    Suppl. Files: 86
    HTML: 225
  • TUBERCULOSIS: MEDICO-LEGAL ASPECTS

    Giuseppe Vetrugno, Fabio De Giorgio, Francesco D'Alessandro
    e2014033
    2014-04-21
    https://doi.org/10.4084/mjhid.2014.033
    2433
    PDF: 1043
    HTML: 2863
  • A MULTICENTRE ICET-A STUDY OF CONFIRMED SARS-COV-2 INFECTION IN PATIENTS WITH HEMOGLOBINOPATHIES: PRELIMINARY DATA FROM 10 COUNTRIES

    Vincenzo De Sanctis
    e2020046
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.046
    2831
    PDF: 1570
    HTML: 304
  • ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

    Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam
    e2022036
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.036
    862
    PDF: 503
    HTML: 387
  • THE DIAGNOSTIC VALUE OF PULSED WAVE TISSUE DOPPLER IMAGING IN ASYMPTOMATIC BETA- THALASSEMIA MAJOR CHILDREN AND YOUNG ADULTS ; RELATION TO CHEMICAL BIOMARKERS OF LEFT VENTRICULAR FUNCTION AND IRON OVERLOAD .

    Seham Ragab
    e2015051
    2015-08-24
    https://doi.org/10.4084/mjhid.2015.051
    1389
    PDF: 868
    HTML: 1355
    Untitled: 189
  • MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT

    Alfredo Marzano
    e2009025
    https://doi.org/10.4084/mjhid.2009.025
    841
    PDF: 486
    HTML: 1303
  • CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL

    Ugo Testa, Prof. Sica, Dr. Pelosi, Dr. Germana Castelli, Prof. Leone
    e2024010
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.010
    4140
    PDF: 3417
    HTML: 202
  • ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

    Teresa L Field, Claudio Anasetti
    e2010019
    2010-07-19
    https://doi.org/10.4084/mjhid.2010.019
    1325
    PDF: 663
    HTML: 1185
  • Guest Editor: Pellegrino Musto AN UPDATE OF THE APPROPRIATE SEQUENCING FOR SALVAGE THERAPIES IN MULTIPLE MYELOMA

    Gregorio Barila', Francesca Rezzonico, Laura Pavan, Alessandro Corso, Renato Zambello
    e2025043
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.043
    1169
    PDF: 956
    HTML: 147
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1430
    PDF: 516
    HTML: 182
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

    Charicleia Kelaidi, Lionel Ades, Pierre Fenaux
    e2011038
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.038
    2474
    PDF: 947
    HTML: 2340
  • IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination

    Giuseppe Auteri, Simona Paglia, Camilla Mazzoni, Mattia Biondo, Marta Venturi, Andre Davide Romagnoli, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Francesca Palandri
    e2023029
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.029
    1424
    PDF: 805
    HTML: 315
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

    Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica
    e2018005
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.005
    4188
    PDF: 1072
    HTML: 1262
  • ACUTE LYMPHOBLASTIC LEUKEMIA EXPERIENCE: EPIDEMIOLOGY AND OUTCOME OF TWO DIFFERENT REGIMENS

    Salah Abbasi, Faten Maleha, Muhannad Shobaki
    e2013024
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.024
    2018
    PDF: 1025
    HTML: 2614
  • OUTCOME OF CANDIDA PARAPSILOSIS COMPLEX INFECTIONS TREATED WITH CASPOFUNGIN IN CHILDREN

    İlker Devrim, Rana İşgüder, Hasan Ağın, Nuri Bayram, Gökhan Ceylan, Yüce Ayhan, Özlem Saraç Sandal, Ferhat Sarı, Ahu Kara, Mine Düzgöl
    e2016042
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.042
    3608
    PDF: 774
    HTML: 849
51 - 100 of 453 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy